Age-specific risks, severity, time course, and outcome of bleeding on long-term antiplatelet treatment after vascular events: a population-based cohort study.
about
Antithrombotics in trauma: management strategies in the older patients.No Significant Association Between Proton Pump Inhibitor Use and Risk of Stroke After Adjustment for Lifestyle Factors and Indication.A three-year prospective study of the presentation and clinical outcomes of major bleeding episodes associated with oral anticoagulant use in the UK (ORANGE study).Percutaneous coronary intervention in the elderly: are drug coated balloons the future?A spotlight on the management of complications associated with myeloproliferative neoplasms: a clinician's perspective.Early time course of major bleeding on antiplatelet therapy after TIA or ischemic stroke.Fighting residual cardiovascular risk in stable patients with atherosclerotic vascular disease: COMPASS in context.External Validation of Risk Scores for Major Bleeding in a Population-Based Cohort of Transient Ischemic Attack and Ischemic Stroke Patients.Aspirin: 120 years of innovation. A report from the 2017 Scientific Conference of the International Aspirin Foundation, 14 September 2017, Charité, Berlin.Benefit-risk profile of cytoreductive drugs along with antiplatelet and antithrombotic therapy after transient ischemic attack or ischemic stroke in myeloproliferative neoplasms.Effects of gastroprotectant drugs for the prevention and treatment of peptic ulcer disease and its complications: a meta-analysis of randomised trials.Association between patient characteristics and magnetically controlled capsule endoscopy findings.Serious hemorrhages after ischemic stroke or TIA - Incidence, mortality, and predictors.Maintenance use of non-steroidal anti-inflammatory drugs and risk of gastrointestinal cancer in a nationwide population-based cohort study in Sweden.Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trialsFactors Associated with Inadequate Management of Antiplatelet Agents in Perioperative Period of Non-Cardiac SurgeriesPractical issues in clinical scenarios involving CKD patients requiring antithrombotic therapy in light of the 2017 ESC guideline recommendationsDevelopment of a standardized definition for clinically significant bleeding in the ASPirin in Reducing Events in the Elderly (ASPREE) trial
P2860
Q42373137-EEC089D3-D317-45CA-9791-D74B6FC7F13DQ47264184-C37AD117-A1EF-40F0-A7E5-1A0850CB1405Q47548974-D52CFB69-2948-4FB9-96B0-D8F4D45E4AFFQ47763813-7BF7E407-58A6-4D95-9A6B-E24B0B045AC1Q47813570-4909D8AC-7A3D-4FE9-8EBC-B0171654B030Q47837629-4107890E-C453-44ED-ABD9-9FBEAE86C9A6Q49549481-1DB99C3F-BDD8-4656-8A03-86A3887B5F15Q49832828-225D6D3F-5327-43DD-AC3E-450983E5BF29Q51411912-03E06124-BA74-4BDD-8DD3-84B4B14C625FQ52657333-EDF1D301-31D9-4975-9DA2-594C3B43BCE1Q52687792-34312127-07D6-4CDC-8CF9-0E07583FF3D9Q55248397-13E4AA18-0CDE-4B1A-84D7-6D658C6744B6Q55279655-65684BC2-B92F-4CFE-9D10-3A91B2FCDF75Q55716567-BF816B45-38CA-44FB-94B2-8A303FF00C8FQ56675489-F75C5134-FCFF-4DC9-BFD2-D56C682AF9FCQ57070950-EFB1F04F-4560-4831-886C-F28BAC0D04A0Q57154436-E232C8AB-03E2-4AE9-9747-10EB0F0989A8Q57179208-74851A21-36D7-4EE1-BA22-EC5143441053
P2860
Age-specific risks, severity, time course, and outcome of bleeding on long-term antiplatelet treatment after vascular events: a population-based cohort study.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Age-specific risks, severity, ...... population-based cohort study.
@en
type
label
Age-specific risks, severity, ...... population-based cohort study.
@en
prefLabel
Age-specific risks, severity, ...... population-based cohort study.
@en
P2860
P50
P1433
P1476
Age-specific risks, severity, ...... population-based cohort study.
@en
P2093
Olivia C Geraghty
P2860
P304
P356
10.1016/S0140-6736(17)30770-5
P407
P577
2017-06-13T00:00:00Z